After close to 100% gain since the March 23 lows of the last year, at the current price of $13 per share we believe Credit Suisse Stock (NYSE: CS) has some more room to go. Credit Suisse, the second-largest Swiss bank, has seen its stock rally from $7 to $13 off the recent bottom compared to the S&P which moved around 65% – the stock is leading the broader markets. The stock growth could be attributed to growth in Credit Suisse’s Investment Bank segment which includes both Investment Banking and Sales & Trading businesses. While the bank did report soft performance in Q3 2020 – with the company falling short of consensus estimates and earnings, its cumulative nine months revenues of $16.5 billion were 2% above the year-ago period, mainly driven by a 133% jump in trading revenues (revenue figures were originally reported in CHF (Swiss Francs), the same has been converted to USD for ease of comparison).
Credit Suisse’s stock has partially reached the level it was at before the drop in February 2020 due to the coronavirus outbreak becoming a pandemic. Despite the healthy rise since the March 23 lows, we feel that the company’s stock still has potential as its revenues have increased during the Covid-19 crisis and its valuation implies it has further to go.
The company’s revenues grew around 10% from $20.9 billion in 2018 to about $22.9 billion in 2019, which translated into a 70% increase in the net income figure over the same period. This unusual increase was due to restructuring expenses incurred in 2018 and lower compensation cost as a % of revenues in 2019. Overall, the net income margin increased from 9.8% in 2018 to 15.2% in 2019.
- What To Expect From Credit Suisse Stock?
- Forecast Of The Day: Credit Suisse’s Swiss Client Assets
- Credit Suisse Stock Missed The Consensus In Q4, Is It Fairly Priced?
- Is Credit Suisse Stock Undervalued?
- What To Expect From Credit Suisse Stock Over The Next One Month?
- Credit Suisse Stock To Miss The Earnings Consensus In Q2, Revenues To Beat Expectations
While the company has seen steady growth in EPS over 2018-2019, its P/E multiple has decreased. We believe the stock is likely to see some upside despite the recent rally and the potential weakness from a recession-driven by the Covid outbreak. Our dashboard “What Factors Drove 21% Change In Credit Suisse Stock Between 2018-End And Now?” has the underlying numbers.
Credit Suisse’s P/E multiple has changed from just below 14x in FY 2018 to around 10x in FY 2019. The company’s P/E is just below 10x now. This leaves some space for upside when the current P/E is compared to levels seen in the past years – P/E multiple of around 14x at the end of 2018.
So Where Is The Stock Headed?
Credit Suisse’s growth over the first nine months of 2020 was mainly due to the strength in its investment banking arm – cumulative nine months investment banking revenues were up 20% y-o-y. While the sales & trading benefited from higher trading activity in the market, the investment banking business enjoyed higher underwriting deal volume. That said, as the economic conditions improve, we expect both the segment revenues to normalize. On the flip side, Credit Suisse’s wealth management segment has suffered in the last year due to a lower interest rate environment, a build-up in provisions for credit losses, a drop in assets under management, and lower performance fees. However, as the economy inches towards normalcy, the lower interest rate environment and negative GDP scenario are likely to improve. Further, provisions for credit losses are expected to see some favorable drop coupled with positive fund inflows in the asset management business. This is likely to benefit the wealth management revenues. Additionally, the bank is likely to re-start its share buyback program in FY 2021. Overall, Credit Suisse’s stock is expected to see some positive movement in the near term.
The actual recovery and its timing hinge on the broader containment of the coronavirus spread. Our dashboard Trends In U.S. Covid-19 Cases provides an overview of how the pandemic has been spreading in the U.S. and contrasts with trends in Brazil and Russia. Following the Fed stimulus — which set a floor on fear — the market has been willing to “look through” the current weak period and take a longer-term view. With investors focusing their attention on 2021 results, the valuations become important in finding value. Though market sentiment can be fickle, and evidence of an uptick in new cases could spook investors once again.
What if you’re looking for a more balanced portfolio instead? Here’s a high quality portfolio to beat the market, with over 100% return since 2016, versus 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently.